China Cimicifuga Trial of Climacteric Complaint Control — CCCCC  

Climacteric Symptoms Clinical Trial

Official title: A Multicentered RCT Study of the Efficacy and Safety of an Extract of Cimicifuga Foetida L. for the Treatment of Climacteric Symptoms of Chinese Women

Status Recruiting

Clinical Trial Summary

This study is designed to determine whether an extract of Cimicifuga Foetida L. is safe and efficacious to relieve the climacteric symptoms of Chinese women

Clinical Trial Description

Extracts of Cimicifuga Racemosa (black cohosh) have been widely used in North America and Europe for decades for the treatment of menopause related problems, either as nutritional supplements or as pharmaceutical products. Previous clinical trials had shown that an extract of Cimicifuga Foetida L.(Ximingting, Luyepharm), which was standardized to have similar components of an extract of Cimicifuga Racemosa, was safe and efficacious to relieve the climacteric symptoms and signs in Chinese women who were recruited according to criteria categorized by theory of Traditional Chinese Medicine.We are interested to know whether it may have the same efficacy and safety profiles when judged with method and standard commonly accepted in western medicine. ;

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment

Related Conditions & MeSH terms

• Climacteric Symptoms

• NCT number: NCT00622986
• Study type: Interventional
• Source: Shandong Luye Pharmaceutical Co., Ltd.
• Contact: Shouqing Lin, MD
• Phone: 86-10-88068846
• Email: shouqing_lin2003@yahoo.com.cn
• Status: Recruiting
• Phase: Phase 4
• Start date: February 2008
• Completion date: February 2009